Medication info
Belmetec Tablet 20 mg (Olmesartan Medoxomil)

Belmetec Tablet 20 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201100828 · Notified 2011.02.22 · Insurance code 643306000

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If an additional reduction in blood pressure is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the medicine at the same time every day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years and older. No overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use of this medicine is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Child dose
<Pediatric patients> The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a condition where blood pressure remains persistently high without any specific cause. This medication helps lower blood pressure, reducing the burden on the heart and blood vessels, and prevents complications such as myocardial infarction or stroke. With consistent use, it aids in maintaining a healthy life through blood pressure control. It is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If an additional reduction in blood pressure is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the medicine at the same time every day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years and older. No overall differences in the efficacy or safety of this medicine have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use of this medicine is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.

Child dose

<Pediatric patients> The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if administered to pregnant women in the second and third trimesters; thus, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals allergic to any components of this medication, during pregnancy or breastfeeding, in patients undergoing kidney dialysis, those with severe liver dysfunction, biliary obstruction, and specific genetic lactose intolerance. Patients with low blood volume or sodium may experience low blood pressure upon initiating this medication, necessitating careful monitoring of their condition and taking appropriate actions as needed. Patients with severe heart failure or impaired kidney function may see a worsening of kidney function while taking this medication, hence regular blood tests to monitor kidney status are crucial. This medication may induce hyperkalemia; therefore, especially in patients with heart failure or kidney dysfunction, routine monitoring of serum potassium levels is recommended. Patients with aortic stenosis, mitral valve stenosis, or obstructive heart disease should take special precautions when using this medication. Dizziness may occur when taking this medication, so it is advisable to avoid hazardous activities such as working at heights or driving machinery. The safety of this medication has been verified in clinical trials involving over 3,800 patients, with dizziness being a common side effect. Other symptoms may include abdominal pain, headache, muscle pain, rash, but most are mild and temporary. If any adverse reactions are severe or persist, consult a physician immediately. This medication may interact with diuretics, potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs, so it is important to inform healthcare providers of any other medications being taken. Particular caution is required for diabetes patients or those with moderate to severe impairment of kidney function to avoid interactions with certain medications. During pregnancy, it should be avoided to prevent severe fetal damage, and in breastfeeding, care should be taken as adverse effects may appear in infants, thereby a careful decision must be made. Safety in children has not been established, hence it is generally not used in pediatric patients. Elderly patients may require dosage adjustments; hence caution is advised during use. In cases of overdose, low blood pressure and palpitations may occur, and appropriate treatment should be obtained as necessary. Although no carcinogenic risks have been reported with long-term use of this medication, immediate consultation with healthcare professionals is necessary if any abnormal symptoms appear during administration.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • flu-like symptoms
Show 38 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial swelling
  • weakness
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal angioedema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma
  • postural dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. Additionally, it is advisable to store it at room temperature, ideally between 1 to 25 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.